Sri Krishna Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Telangana, Telangana, India, established in 1974.
1974 Telangana, Telangana, India Active
Last Updated:
Access Report
About Sri Krishna Pharmaceuticals Limited

Sri Krishna Pharmaceuticals Limited, a active public limited company, was established on 26 September 1974 in Telangana, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1974PLC001790. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹11.92 Cr.

Formerly known as Sri Krishna Pharmaceuticals Private Limited. It upholds a compliant status. Employing 1,459 professional, Its leadership includes Venkatakrishna Reddy Vempalli (Managing Director), Venkata Subba Reddy Vempalle (Whole-Time Director), Sunitha Reddy Reddivari (Director). Past directors included Hrudaya Purna Rajeshwari Annavajhala, Venkatakrishna Reddy Vempalli, Shilpa Bung. It holds ₹274.50 Cr open charges and ₹194.84 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at C-4,Industrial Area, Uppal Hyderabad, Telangana, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1974PLC001790

  • Registration Number

    001790

  • Incorporation Date

    26 September 1974

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹11.92 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 11.92 Cr
  • Company Age 51 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 274.50 Cr
  • Satisfied Charges ₹ 194.84 Cr
  • Revenue Growth **** -3.35%
  • Profit Growth **** -52.42%
  • Ebitda **** -34.08%
  • Net Worth 1.61%
  • Total Assets **** 2.41%
Company report

Sri Krishna Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sri Krishna Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sri Krishna Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Venkatakrishna Reddy Vempalli Managing Director 15 Oct 1997 Current
Venkata Subba Reddy Vempalle Whole-Time Director 26 Sep 1974 Current
Sunitha Reddy Reddivari Director 01 Feb 2023 Current
Venkateswar Rao Sarvepalli Director 31 Oct 2014 Current
Pranesh Raj Mathur Whole-Time Director 17 Feb 2014 Current
Nikhil Bihari Pandey Cfo 21 Sep 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 14 Mar 2015 Past
Pramod Abcsdd Director 29 Aug 2008 Past
Pramod Abcsdd Company Secretary 15 Dec 2020 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 19 Jun 2009 Past
Pramod Abcsdd Whole-Time Director 05 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Krishna Pharmaceuticals.

Sri Krishna Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.35% decrease. The company also saw a substantial fall in profitability, with a 52.42% decrease in profit. The company's net worth moved up by a moderate rise of 1.61%.

Sri Krishna Pharmaceuticals revenue growth over time
Sri Krishna Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -3.35%
*******
*******
*******
*******
Revenue from Operations
*******
 -3.15%
*******
*******
*******
*******
Total Assets
*******
 2.41%
*******
*******
*******
*******
Profit or Loss
*******
 -52.42%
*******
*******
*******
*******
Net Worth
*******
 1.61%
*******
*******
*******
*******
EBITDA
*******
 -34.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Krishna Pharmaceuticals?

In 2023, Sri Krishna Pharmaceuticals had a promoter holding of 89.09% and a public holding of 10.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,745,000,000.00

Satisfied Charges

₹1,948,358,757.00

Charges Breakdown by Lending Institutions
  • Others : 147.00 Cr
  • Axis Bank Limited : 82.50 Cr
  • Citi Bank N.A. : 45.00 Cr
Latest Charge Details
Date Lender Amount Status
28 Mar 2024 Others ₹30.00 Cr Open
26 Apr 2021 Citi Bank N.A. ₹9.00 Cr Open
07 Jan 2021 Others ₹77.00 Cr Open
22 Oct 2018 Others ₹40.00 Cr Open
11 Jan 2016 Axis Bank Limited ₹82.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sri Krishna Pharmaceuticals?

Sri Krishna Pharmaceuticals has a workforce of 1459 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Krishna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Krishna Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Krishna Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Subramaniam Krishnan Anikode was appointed as a Additional Director was appointed as a Additional Director on 28 Oct 2025 & has been associated with this company since 3 months 26 days . was completed.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 82.50 Cr registered on 11 Jan 2016 with Charge ID 10617348 was modified on 29 Aug 2025. was documented.

  • Annual General Meeting

    The activity Sri Krishna Pharmaceuticals Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was completed.

  • Charges

    A charge registered on 30 Mar 2021 via Charge ID 100438325 with Others was fully satisfied on 19 Jul 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Sri Krishna Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Nikhil Bihari Pandey was appointed as a CFO was appointed as a CFO on 14 Oct 2024 & has been associated with this company since 1 year 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sri Krishna Pharmaceuticals Limited?

The CIN of Sri Krishna Pharmaceuticals Limited is U24230TG1974PLC001790.

Where is Sri Krishna Pharmaceuticals Limited headquartered?

Sri Krishna Pharmaceuticals Limited is headquartered at C-4,Industrial Area, Uppal Hyderabad, Telangana, Telangana, 500039.

When was Sri Krishna Pharmaceuticals Limited incorporated?

Sri Krishna Pharmaceuticals Limited was incorporated on 26 September 1974.

Who are the current directors of Sri Krishna Pharmaceuticals Limited?

The current directors of Sri Krishna Pharmaceuticals Limited are

What is the primary industry of Sri Krishna Pharmaceuticals Limited?

The primary industry of Sri Krishna Pharmaceuticals Limited is Manufacturing.

Is Sri Krishna Pharmaceuticals Limited a listed company?

Sri Krishna Pharmaceuticals Limited is unlisted.

What is the capital structure of Sri Krishna Pharmaceuticals Limited?

The authorized capital of Sri Krishna Pharmaceuticals Limited is ₹15.00 Cr, and the paid-up capital is ₹11.92 Cr.

What is the compliance status of Sri Krishna Pharmaceuticals Limited?

The compliance status of Sri Krishna Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available